A Safety and Efficacy study of BOTOX® (Botulinum Toxin Type A) in patients with Urinary Incontinence due to bladder conditions.
Phase 4
- Conditions
- Health Condition 1: null- Urinary Incontinence
- Registration Number
- CTRI/2015/11/006353
- Lead Sponsor
- Allergan Healthcare India Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 250
Inclusion Criteria
Patients with urinary incontinence (due to NDO, eg, as a result of SCI or MS, or due to OAB) who have an inadequate response to or are intolerant of an anticholinergic medication
Exclusion Criteria
Not provided
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method